---
title: "Astec Lifesciences Ltd (ASTEC) — Share Price, Financials & Analysis"
symbol: "ASTEC"
company: "Astec Lifesciences Ltd"
canonical: "https://tapetide.com/stocks/ASTEC"
isin: "INE563J01010"
nse_symbol: "ASTEC"
bse_code: "533138"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 1570.94
generated_at: "2026-09-13T18:32:46.933Z"
---

# Astec Lifesciences Ltd (ASTEC)

Canonical page: https://tapetide.com/stocks/ASTEC

## Company

- **NSE Symbol:** ASTEC
- **BSE Code:** 533138
- **ISIN:** INE563J01010
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2009-11-25
- **CEO:** Mr. Burjis Nadir Godrej
- **Employees:** 555
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** godrejastec.com

## About

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1] [2] [3]

## Latest Price

- **Price:** ₹699.8
- **Change:** -16 (-2.24%)
- **Open:** ₹716
- **Day High:** ₹722.4
- **Day Low:** ₹694
- **Previous Close:** ₹715.8
- **Volume:** 83837
- **As Of:** 2026-09-11T10:24:54+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:48.284117Z.

- **Market Cap:** ₹1570.94 Cr
- **Classification:** Microcap
- **P/E (reported):** -23.8
- **EPS (TTM):** ₹-29.89
- **EPS (reported):** ₹0
- **Book Value:** ₹175.29
- **Price to Book:** 4.06
- **Dividend Yield:** 0.21%
- **ROE:** -20.69%
- **ROCE:** -10.51%
- **Debt to Equity:** 1.15
- **Revenue (yearly):** ₹453.2 Cr
- **Net Income:** ₹-80.9 Cr
- **EBITDA:** ₹0.5 Cr
- **52-Week High:** ₹941.75
- **52-Week Low:** ₹513.4
- **RSI (14):** 65.86

## Tapetide Score

- **Score:** 28 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 1.1 (of 4473 scored stocks)
- **Confidence:** 93%
- **Data coverage:** 86%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 19.24 | 9% |
| growth | 47.47 | 9% |
| momentum | 20.08 | 12% |
| ownership | 47.11 | 24% |
| quality | 16.03 | 22% |
| valuation | 17.99 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 3.99 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -4.18% over past five years.
- Company has a low return on equity of -26.0% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.3.21 Cr.
- Company has high debtors of 202 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -860.83% | -889.73% | -441.99% |
| ebitda margin growth | -99.15% | -100.77% | -300% | -99.5% |
| net income growth | -139.74% | -39.94% | 72.49% | -189.99% |
| revenue growth | -47.7% | 17.14% | -11% | -4% |
| roce | — | -48.02% | 66.3% | 1.46% |
| roe | 141.42% | -63.9% | -30.23% | -191.31% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 111 | 51 | 154 | 69 | 99 | 94 | 120 | 91 | 74 | 125 | 159 | 84 |
| Expenses | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 121 | 149 | 84 |
| Operating Profit | -3 | -18 | 13 | -46 | -20 | -6 | 6 | -11 | -7 | 4 | 9 | -1 |
| OPM % | -3.1 | -36 | 8 | -67 | -20 | -6 | 4.6 | -12 | -9 | 3.2 | 6 | -0.8 |
| Other Income | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | -1 | 3 | 1 |
| Interest | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 |
| Depreciation | 9 | 9 | 9 | 9 | 11 | 11 | 12 | 11 | 10 | 11 | 12 | 11 |
| Profit before tax | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 |
| Tax % | -24 | -24 | 4 | -36 | 0 | 61 | 3 | 0 | 0 | 0 | -2 | 0 |
| Net Profit | -13 | -24 | -1 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 |
| EPS in Rs | -6 | -10.86 | -0.43 | -17.73 | -17.21 | -18.03 | -7.18 | -14.75 | -10.96 | -7.05 | -3.48 | -8.4 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 368 | 431 | 523 | 555 | 677 | 628 | 458 | 381 | 448 | 441 |
| Expenses | 299 | 354 | 437 | 443 | 522 | 551 | 464 | 448 | 453 | 435 |
| Operating Profit | 69 | 76 | 85 | 112 | 154 | 77 | -6 | -66 | -4 | 6 |
| OPM % | 19 | 18 | 16 | 20 | 23 | 12 | -1.3 | -17 | -1 | 1.3 |
| Other Income | 12 | 11 | 12 | 8 | 10 | 13 | 6 | 6 | 3 | 3 |
| Interest | 11 | 12 | 13 | 5 | 9 | 21 | 25 | 37 | 35 | 31 |
| Depreciation | 15 | 19 | 23 | 26 | 34 | 34 | 36 | 44 | 45 | 44 |
| Profit before tax | 56 | 56 | 61 | 89 | 121 | 35 | -62 | -141 | -81 | -67 |
| Tax % | 37 | 36 | 23 | 27 | 26 | 27 | -24 | -4 | 0 | — |
| Net Profit | 35 | 36 | 48 | 65 | 90 | 26 | -47 | -135 | -81 | -67 |
| EPS in Rs | 15.65 | 16.03 | 21.21 | 29.04 | 40.12 | 11.41 | -20.95 | -60.16 | -36.32 | -29.89 |
| Dividend Payout % | 8 | 8 | 6 | 5 | 3 | 12 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 |
| Reserves | 119 | 150 | 183 | 227 | 290 | 377 | 400 | 350 | 215 | 368 |
| Borrowings | 127 | 125 | 176 | 99 | 187 | 279 | 341 | 494 | 555 | 449 |
| Other Liabilities | 69 | 119 | 83 | 226 | 181 | 221 | 219 | 112 | 92 | 102 |
| Total Liabilities | 334 | 413 | 461 | 572 | 678 | 897 | 979 | 975 | 881 | 942 |
| Fixed Assets | 103 | 115 | 167 | 194 | 213 | 340 | 318 | 386 | 499 | 459 |
| CWIP | 8 | 42 | 19 | 24 | 116 | 23 | 127 | 165 | 21 | 20 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 223 | 256 | 275 | 354 | 349 | 534 | 534 | 424 | 361 | 463 |
| Total Assets | 334 | 413 | 461 | 572 | 678 | 897 | 979 | 975 | 881 | 942 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 19 | 65 | 15 | 168 | -8 | 24 | 75 | 10 | -8 | -81 |
| Cash from Investing Activity | -18 | -49 | -52 | -74 | -73 | -104 | -113 | -135 | -15 | -4 |
| Cash from Financing Activity | -1 | -18 | 37 | -95 | 81 | 80 | 38 | 125 | 24 | 94 |
| Net Cash Flow | 1 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Free Cash Flow | -1 | 15 | -37 | 123 | -111 | -80 | -42 | -125 | -24 | -86 |
| CFO/OP | 41 | 116 | 41 | 219 | 13 | 34 | 104 | -211 | 20 | 1796 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 135 | 122 | 103 | 112 | 123 | 148 | 90 | 135 | 141 | 202 |
| Inventory Days | 133 | 122 | 121 | 131 | 113 | 176 | 268 | 224 | 196 | 169 |
| Days Payable | 116 | 155 | 83 | 218 | 137 | 179 | 161 | 102 | 100 | 107 |
| Cash Conversion Cycle | 152 | 89 | 142 | 25 | 100 | 145 | 197 | 256 | 237 | 263 |
| Working Capital Days | 1 | -8 | -2 | 8 | 4 | 12 | -17 | -1 | -26 | -56 |
| ROCE % | 20 | 22 | 20 | 20 | 22 | 22 | 8 | -4 | -13 | -5 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 66.75% | 66.75% | 66.75% | 66.75% | 66.75% | 66.75% | 70.87% | 70.87% | 72.42% | 71.97% | 71.97% | 71.96% |
| FIIs | 1.33% | 1.28% | 1.25% | 1.03% | 0.53% | 1.2% | 0.25% | 0.02% | 0% | 0.04% | 0.02% | 0.01% |
| DIIs | 9.15% | 9.74% | 7.88% | 3.38% | 4.51% | 5.41% | 4.34% | 4.26% | 4.01% | 3.17% | 3.34% | 3.33% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 17.91% | 18.19% | 19.62% | 22.52% | 21.95% | 20.71% | 19.62% | 19.98% | 19.32% | 20.87% | 20.81% | 20.48% |
| Others | 4.86% | 4.03% | 4.49% | 6.33% | 6.26% | 5.93% | 4.91% | 4.87% | 4.25% | 3.95% | 3.86% | 4.22% |
| No. of Shareholders | 18722 | 19244 | 19848 | 19955 | 19727 | 19057 | 18689 | 18549 | 18276 | 22293 | 21041 | 19889 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 6 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 621.51 | Buy |
| EMA (10) | 648.31 | Buy |
| SMA (20) | 606.98 | Buy |
| EMA (20) | 627.87 | Buy |
| SMA (50) | 635.27 | Buy |
| EMA (50) | 639.01 | Buy |
| SMA (100) | 687.62 | Buy |
| EMA (100) | 658.41 | Buy |
| SMA (200) | 673.46 | Buy |
| EMA (200) | 680.58 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 62.51 | Neutral |
| MACD (12,26,9) | 14.17 | Buy |
| Stochastic (14,3,3) | 77.52 | Neutral |
| ADX (14) | 40.84 | Buy |
| Williams %R (14) | -33.24 | Neutral |
| ATR (14) | 38.19 | High Volatility |
| ROC (12) | 17.91 | Buy |
| Stoch RSI (14) | 72.22 | Neutral |
| UO (7,14,28) | 62 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 0 | 0% |
| Hold | 0 | 0% |
| Sell | 1 | 100% |

Based on 1 analyst ratings, observed at 2026-09-11T04:47:48.270405+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-11 | [Response To BSE E-Mail Seeking Clarification On Price Movement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8b053a0-6a2f-4c04-bbaf-8b1defcaabbc.pdf) |
| 2026-09-09 | [Reply To BSE Query Regarding Volume Movement Dated September 9 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d895ba15-bddc-4bbc-b167-9de7480b96b9.pdf) |
| 2026-08-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ee62f98-79e4-45ce-98d5-d9578b9b83a1.pdf) |
| 2026-07-31 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c16350e-17be-4371-8483-0417892b558c.pdf) |
| 2026-07-31 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1138907-ecfb-497c-9cf7-c05df0119f3a.pdf) |
| 2026-07-31 | [32Nd Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f9be7ef-1f68-43ea-9cc2-23f22a9a5858.pdf) |
| 2026-07-31 | [32Nd Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c393c5ce-fa82-46c7-b25b-a508cd24101d.pdf) |
| 2026-07-31 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ef7fb4-e20d-4ef9-a501-f01d123439f5.pdf) |
| 2026-07-31 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb175c2a-87f2-49e5-b39f-4aec1c5c5978.pdf) |
| 2026-07-21 | [Board Meeting Intimation for Intimation Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dec141b-10f1-46d5-928d-dffab0971336.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Astec Lifesciences says no undisclosed developments exist regarding recent price movement. | [Clarification To BSE Regarding Price Movement 9h - Astec Lifesciences says no undisclosed developments exist regarding recent price movement.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/77ca05d9-0b08-4405-ac5c-5559afdd8390.pdf) |
| 9 Mar - Sold 26% (2,600 shares) in Clean Max Andes to Clean Max Enviro for Rs.26,000 on 9 Mar 2026. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations') - Disinvestment Of Equity Shares Held In Clean Max Andes Private Limited 9 Mar - Sold 26% (2,600 shares) in Clean Max Andes to Clean Max Enviro for Rs.26,000 on 9 Mar 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/67ec82f8-5bdc-4b50-855f-01e57fb27d5e.pdf) |
| 8h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and proposed postal ballot appointments. | [Board Meeting Outcome for Outcome Of Board Meeting 8h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and proposed postal ballot appointments.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c9957d3e-8089-49e6-a744-2e7eac48c7a4.pdf) |
| 7h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and proposed postal ballot on appointments and RPTs. | [Financial Result 7h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and proposed postal ballot on appointments and RPTs.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4fe16a1f-f6fb-4a08-a542-352ee19c9106.pdf) |
| 7h - Astec Lifesciences announced Q4 FY26 and FY26 audited results; FY26 income ₹453.2 crore, loss ₹80.9 crore. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 7h - Astec Lifesciences announced Q4 FY26 and FY26 audited results; FY26 income ₹453.2 crore, loss ₹80.9 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4d58e25a-b30c-409b-9012-adcb222412f4.pdf) |
| 6h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and sought postal ballot approvals. | [Book Closure For 32Nd Annual General Meeting 6h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and sought postal ballot approvals.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5eb4a300-59bf-438b-a61a-7e9209775a7b.pdf) |
| 6h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and proposed postal ballot for director appointments and RPTs. | [32Nd AGM 6h - Board approved FY26 audited results, fixed 31 July 2026 AGM, and proposed postal ballot for director appointments and RPTs.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9d56758d-cc77-43e2-8ba2-34ce4b0b598a.pdf) |
| 6 Feb - Replied to BSE on volume spike, confirmed compliance; no undisclosed developments (6 Feb 2026). | [Reply On Significant Increase In The Volume Of Security 6 Feb - Replied to BSE on volume spike, confirmed compliance; no undisclosed developments (6 Feb 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3de741b-0b8d-41b2-8c5a-de0291135fdf.pdf) |
| 4 Feb - Q3 FY26 transcript: 9M revenue INR11.94bn, PAT INR1.54bn, record quarterly orders INR6.56bn, FY27 guidance INR2,200+ crore. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 Feb - Q3 FY26 transcript: 9M revenue INR11.94bn, PAT INR1.54bn, record quarterly orders INR6.56bn, FY27 guidance INR2,200+ crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1e575433-0bdf-4435-b6b1-d9f12ad5a316.pdf) |
| 30 Jan - Audio recording of post-results conference call for quarter and nine months ended Dec 31, 2025 available on company's website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Jan - Audio recording of post-results conference call for quarter and nine months ended Dec 31, 2025 available on company's website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/58168f8f-60ce-409d-8807-7204e92642fe.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-31 | [Financial Result For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=606f2dce-0e7b-491c-acc7-aae65dd2767a.pdf) |
| 2026-04-27 | [Financial Result](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fe16a1f-f6fb-4a08-a542-352ee19c9106.pdf) |
| 2026-01-30 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e630a3b-1e01-4e15-b0e1-603f7729c0cb.pdf) |
| 2025-10-29 | [Financial Result For The Quarter And Half-Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6de009bf-b393-4615-b6c8-ed04f16cddc6.pdf) |
| 2025-10-29 | [Financial Result For The Quarter And Half-Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f97bb76-aa8d-4f12-9d9d-7bf2a4d4cf3c.pdf) |
| 2025-07-28 | [QUATERLY FINANCIAL RESULTS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=609c9206-1407-47fe-b13a-71e03b9eda95.pdf) |
| 2025-04-23 | [Outcome Of The Board Meeting Held On Wednesday April 23 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fec2f06c-392d-4c61-ba73-6fe2f8683068.pdf) |
| 2025-01-27 | [Outcome Of The Board Meeting Held On Monday 27Th January 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f3d9746-75fa-4130-854d-9ec8550bca8f.pdf) |
| 2024-10-25 | [Outcome Of The Board Meeting Dated October 25, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73a09a2d-1dc4-4e32-95a1-b372db992668.pdf) |
| 2024-10-25 | [Financial Results- September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6703b502-a593-402a-ad3e-e8803b77f214.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17783b69-1925-4c7f-a0d4-97c6c31df31d.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba781958-d447-43f9-a7cf-2d1fecf6a367.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80412e6d-1c7b-4ad3-a644-39c7585e49ea.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34dc9be7-e19f-45d2-ba0e-5053cd7b9cf9.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c83496de-aca9-48d8-b4b5-642ed791ee9e.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0cc4e5a-852d-4d23-b762-46265e2e8f61.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e72abe58-4c0f-447f-9918-1a86e5a4e5c7.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533138/73415533138.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533553/75968533553.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533138/68742533138.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/244e0fa6-fc6d-4ef2-8549-8774eb792405.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17befc9f-20da-497b-aa4a-efb4c251974f.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ccb68e8-20dc-4c02-a73f-39b1f8787843.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e853f000-59c4-497f-9a38-787caef5ef9d.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/955f24c6-c7b4-4e35-b345-2b7d3ba41baf.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e853f000-59c4-497f-9a38-787caef5ef9d.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a4d9095-5e68-416a-9318-cc18cfc532e9.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fcc00957-54c9-41c9-9fe8-c7159000ccb4.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02461f50-26fc-431b-b33c-8311c4024cbb.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/63852e96-42b2-41a4-a7d3-64ab842f1f58.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2022-11-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=955f24c6-c7b4-4e35-b345-2b7d3ba41baf.pdf) |
| 2022-05-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b459c1da-ad62-4ce3-b199-5fe0e811ee86.pdf) |
| 2021-11-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcc00957-54c9-41c9-9fe8-c7159000ccb4.pdf) |
| 2021-05-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39d90999-59ff-4475-99f3-0ede071b3f0b.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2022-10-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bd3d2f2-62d0-4be1-a6dc-d83b7f47b5c7.pdf) |
| 2022-05-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df2e3057-c329-4fb2-a549-3ab34469f581.pdf) |
| 2021-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c70edbbf-5cbd-47b3-87d5-76a2617d59d6.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:32:46.933Z.